Work

Studies evaluate de‐escalation of treatment for certain patients with breast cancer

Year: 2025

Type: article

Abstract: This news section offers Cancer readers timely information on events, public policy analysis, and topical issues. In this issue, studies evaluate the de‐escalation of treatment for certain patients with breast cancer. In addition, no overall survival benefit was found when adding venetoclax for patients with relapsed or refractory multiple myeloma, and APOLLO trial confirms ATRA—ATO use for patients with high‐risk acute promyelocytic leukemia.

Source: Cancer

DOI: 10.1002/cncr.70135

Author: Leah Lawrence

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4416936369

FWCI:

Cites: 1

Cited by:

Related to: